Searchable abstracts of presentations at key conferences in endocrinology

ea0011p328 | Diabetes, metabolism and cardiovascular | ECE2006

Comparison between NPH insulin and insulin glargine in intensive insulin therapy in type 1 diabetes mellitus

Pešic M , Radenkovic S , Živic S , Velojic M , Dimic D , Mikic D

Background and Aims: Insulin glargine is a long acting insulin analog that mimics normal basal insulin secretion without pronounced peaks. The aim of this study was to compare insulin glargine with NPH insulin for basal insulin supply in patients with type 1 diabetes.Materials and Methods: A total of 48 type 1 diabetics (mean age 27 yr, BMI 23,1 kg/m2) on long term intensive insulin therapy (IIT) were randomized into 3 different regimens of ba...

ea0011p931 | Thyroid | ECE2006

Fine-needle aspiration biopsy of thyroid nodules

Radenkovic S , Pešic M , Kocic R , Dimic D , Mikic D , Velojic Golubovic M

Background: The most common method for evaluation of a suspicious thyroid nodule is a fine needle aspiration biopsy (FNAB). Together with ultrasound examination, thyroid scanning using pertechnetate and functional thyroid testing it helps in distinguishing between benign and malignant disease.Objective: Aim of this study is to assess accuracy of FNAB in the diagnostic evaluation of thyroid nodules.Patients: We retrospectively analy...

ea0011p350 | Diabetes, metabolism and cardiovascular | ECE2006

Comparison between premixed insulin aspart 30 vs premixed human insulin 30/70 in combination with metformin in obese type 2 diabetic patients

Mikic D , Golubovic MV , Pesic M , Kocic R , Radenkovic S , Dimic D , Antic S

Background and aims: Many obese patients with type 2 diabetes mellitus (T2DM) are not adequatly controlled with oral antidiabetic therapy (OAD), even with combination between metformin and sulfonylurea (SU). When OADs no longer maintain good glycaemic control in obese T2DM, it is necessary to add insulin therapy. The aim of this study is to compare the effect of adding premixed insulin aspart 30(BIAsp30) vs. premixed human insulin 30/70 (BHI30) to support metformin therapy in ...

ea0011p351 | Diabetes, metabolism and cardiovascular | ECE2006

Effect of repaglinide vs glimepirid on glycaemic control in overweight and obese patients with type 2 diabetes mellitus uncontrolled by metformin

Golubovic MV , Mikic D , Pesic M , Dimic D , Radenkovic S , Kocic R

Background and aims: Metformin is the drug of first choice in obese patients with type 2 diabetes (T2DM), but in some patients it is not possible to achieve good glycaemic control by using metformin only. Starting from a fact that T2DM is a heterogeneous disorder due to the interaction of impaired early insulin secretion and peripheral insulin resistance, the aim of the present study was to evaluate and compare the efficacy of repaglinide vs. glimepirid on glycaemic control of...